Sens. Jacky Rosen (D-NV) and Mitt Romney (R-UT) introduced legislation Friday (May 27) that would direct the Government Accountability Office (GAO) to study the impact of nonprofit generic drug makers on the drug industry and the barriers to their prominence. The bill is meant to help nonprofit generic drug makers, but it’s a far cry from Rosen’s previous bill, which would make it easier for them to acquire nonprofit tax-exempt status, provide them grants and low-interest loans, and waive FDA...
IDP Issue:
Inside Drug Pricing - 05/30/2022